A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Anemia is prevalent among patients with rheumatoid arthritis, according to study findings published in Cureus.

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

Now, AI technology can help in early detection of diseases like arthritis and lupus. | Health News | Patrika News ...

OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...

Artificial intelligence (AI) can significantly aid in early detection of autoimmune diseases, like rheumatoid arthritis and ...

RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, announced today the close of a $15 million Series A financing co-led by SPRIM ...

Following the negative Phase I trial outcome for its autoimmune disease treatment, the company is cutting 73% of jobs.

IGM Biosciences (IGMS) is slashing its workforce by 73% and discontinuing development of two of its lead drug candidates in ...

The biotech wants to create one-time, potentially curative treatments for rheumatoid arthritis and other autoimmune diseases by editing the HLA gene.

IGM Biosciences (NASDAQ: IGMS), a biotechnology company, has seen a sharp 67% drop in its stock value on Friday following the suspension of two of its treatments ...